RPRX Dividend: Royalty Pharma PLC Yield Insights

根据最新的财务报表（Form-10K），Royalty Pharma PLC 的总资产为 $18,222，净profit为 $858

Royalty Pharma PLC 的流动比率是 1.61，净利 margin 为 37.91，每股销售为 $3.8。

Currently Royalty Pharma PLC data is not available.

yes，根据最新的财务报表，Royalty Pharma PLC 的净profit为 $858

yes，Royalty Pharma PLC 的负债为 11,276

Royalty Pharma PLC 的总流通股为 589.11

Income

Balance sheet

Cash flow

Annual

Quarterly

RPRX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,349	2,263	2,354	2,237	2,289	2,122
Revenue Growth (YoY)	4%	-4%	5%	-2%	8%	17%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	570	236	249	227	182	181
Research & Development	402	2	52	177	200	26
Operating Expenses	817	971	862	1,314	858	461
Other Non Operating Income (Expenses)	-8	-1	-21	-14	-5	-2
Pretax Income	1,302	1,330	1,700	230	1,241	1,702
Income Tax Expense	0	0	0	0	0	0
Net Income	764	858	1,134	42	619	495
Net Income Growth	-33%	-24%	2,600%	-93%	25%	-79%
Shares Outstanding (Diluted)	559.61	594.1	602.9	438	414.8	375.5
Shares Change (YoY)	-6%	-1%	38%	6%	10%	-37%
EPS (Diluted)	1.36	1.44	1.88	0.1	1.49	1.32
EPS Growth	-30%	-23%	1,780%	-93%	13%	-67%
Free Cash Flow	944	263	872	402	-174	-147
Free Cash Flow Per Share	1.68	0.44	1.44	0.91	-0.41	-0.39
Gross Margin	--	--	--	--	--	--
Operating Margin	65.21%	57.09%	63.38%	41.21%	62.47%	78.22%
Profit Margin	32.52%	37.91%	48.17%	1.87%	27.04%	23.32%
Free Cash Flow Margin	40.18%	11.62%	37.04%	17.97%	-7.6%	-6.92%
EBITDA	--	1,292	1,492	927	1,453	1,683
EBITDA Margin	--	57.09%	63.38%	41.43%	63.47%	79.31%
D&A For EBITDA	--	0	0	5	23	23
EBIT	1,532	1,292	1,492	922	1,430	1,660
EBIT Margin	65.21%	57.09%	63.38%	41.21%	62.47%	78.22%
Effective Tax Rate	0%	0%	0%	0%	0%	0%